Diabetes, Obesity & Metabolism, 25 (4), 961964
Liraglutide The injectable GLP-1 analogue, liraglutide (Victoza), is FDA approved for once-daily subcutaneous administration in combination with diet and exercise for the treatment of patients with T2DM
Originally developed to treat Type 2 diabetes, GLP-1 medications are now widely used for weight management
Last reviewed: June 20, 2026 Last updated: June 20, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
This makes it a suitable option for those looking to experience weight loss while also managing a cardiovascular issue
In the case of many large employer plans, insurance companies leave the choice up to the employer